chevron_leftBack
As of 24 April 2025, Abbott India Ltd. has a market cap of $7.72B USD, ranking #2071 globally and #143 in India. It ranks #182 in the Healthcare sector, and #30 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$7.72BUSD
658.45B INR
Enterprise Value
$7.58BUSD
648.0B INR
Revenue (TTM)
$731.65MUSD
62.43B INR
EBITDA (TTM)
$181.24MUSD
15.5B INR
Net Income (TTM)
$156.39MUSD
13.34B INR
EBITDA Margin
25%
Profit Margin
21%
PE Ratio
49.3
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Swati Dalal
open_in_new
Employees
3,814
Founded
1910
Website
abbott.co.in
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.8% | 4.6% | 2.4% | 12% | 6.3% | 19% |
Upcoming Earnings
Earnings Date
Fri, May 9
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ABBOTINDIA
Abbott India Ltd
ISIN: INE358A01014
Shares Out.:
Shares Outstanding:
21.249M1
Shares Float:
5.315M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
30.47K INR | |
|
500488
(ABBOTINDIA)
Abbott India Ltd
ISIN: INE358A01014
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
30.9K INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Abbott India Ltd.
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
